Excellent talk on pediatric #MS#MOGAD a& #NMOSD from @tweetsatakash covering all the latest in acute & maintenance treatment of these diseases along with emerging clinical trials in the field 👇
Comparative Effectiveness of Treatments for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Congrats @tweetsatakash and colleagues!
https://t.co/Twh1JQp9jt
New in @GreenJournal: multicenter study of 312 children with MOGAD across the US Network of Pediatric MS Centers.
IVIG was the only therapy significantly associated with reduced relapse risk.
Grateful to our collaborators, patients, and families.
https://t.co/XppwBRsOT5
Can children with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) have paramagnetic rim lesions (PRLs)? Apparently, No! This analysis of 65 patients and 130 scans found exactly zero, suggesting they are specific for MS. https://t.co/AV1TzPAwde
Our new study on pediatric MOGAD:
No PRLs found (key differentiator from MS); CVS in ~30% of lesions - detection is higher in remission;
CVS- lesions resolve more often than CVS+
Timing of MRI matters for these biomarkers!
Read more: https://t.co/Xny2LKUFse
Meet the experts in 2 weeks at TSF's San Francisco Patient Day for #NMOSD & #MOGAD 🧠
We invite patients, caregivers, clinicians, researchers and advocates from and around the Bay Area to join us for a day dedicated to education & community
Register: https://t.co/JEaVEHCFvY
Lipids play a key role in neuroinflammation & injury in #MultipleSclerosis
Structural lipids predict NfL levels, indicating axonal damage. PUFAs protect against future disease activity.
https://t.co/YmdERndZ67
@PavanBhargavaMD@MRenselMD@nationalmssoc @NIH_NINDS
#LymeDisease & #Papilledema: Findings from a 25-year retrospective study reveal that most children recover fully after treatment, regardless of cerebrospinal fluid pleocytosis or antibiotic route.
https://t.co/TkfpEIhjj8
Clinical and Magnetic Resonance Imaging Outcomes in Pediatric-Onset MS Patients on Fingolimod and Ocrelizumab - Multiple Sclerosis and Related Disorders https://t.co/YN0rnKutBc
This case highlights an unusual presentation of severe MOGAD, emphasizes the potential benefit of plasma exchanges in severe MOGAD cases refractory to steroid treatment, and demonstrates how assessment of CSF IL-6 may help guide treatment decisions: https://t.co/CiSDRwbArb
@drmankad@MirskyDavid I'm a resident, and cannot view the Live lectures every Saturday due to work. If the old lectures are made available, it will be helpful.